.svg){kind=small}
Nov-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the dynamic landscape of cannabis brands, Beard Bros Pharms has shown varied performance across different categories and states. In California, the brand has made a notable impact in the Tincture & Sublingual category, securing a rank of 21 in August 2025. However, in the subsequent months, they did not maintain a position within the top 30, indicating a potential decline or increased competition in this segment. This movement suggests that while Beard Bros Pharms had a strong presence initially, sustaining that momentum in California's competitive market remains a challenge.
Conversely, in the Concentrates category in California, Beard Bros Pharms did not appear in the top 30 rankings from August to November 2025. This absence highlights a significant opportunity for growth or perhaps a strategic pivot needed to capture market share in this particular category. Despite the lack of top rankings in Concentrates, the brand's overall sales figures indicate a steady presence in the market, suggesting that while certain categories may not reflect top-tier performance, Beard Bros Pharms continues to engage with consumers effectively in other ways.
Competitive Landscape
In the California concentrates market, Beard Bros Pharms has experienced notable fluctuations in its competitive positioning. Despite not ranking in the top 20 from August to November 2025, the brand's sales trajectory suggests a need to reevaluate its market strategies. In contrast, Team Elite Genetics has maintained a strong presence, consistently ranking within the top 25, although it experienced a significant drop to 59th place in November. This indicates potential volatility that Beard Bros Pharms could capitalize on. Meanwhile, Proof and Galaxy (CA) have shown more stable rankings, with Proof improving its position from 76th in September to 68th in October, and Galaxy peaking at 70th in September. These brands, while not leading, demonstrate resilience and could serve as benchmarks for Beard Bros Pharms to enhance its competitive edge. Additionally, Smoakland re-entered the rankings in November at 94th, illustrating the dynamic nature of the market and the opportunities for Beard Bros Pharms to strategize for a comeback.
Notable Products
In November 2025, the High THC Full Spectrum Oil Syringe (1g) maintained its top position in the Concentrates category with sales reaching 613 units, showcasing consistent dominance as it has been ranked first since August 2025. The THC:CBD 20:1 HighTHC Spectrum Tincture (600mg THC, 30mg CBD, 30ml, 1oz) improved its ranking to second in the Tincture & Sublingual category, despite a decline in sales from previous months. The CBD/THC 10:1 High Full Spectrum Oil (1g) saw a notable climb in ranks, moving from fifth in September to third in November in the Concentrates category. Similarly, the CBD/THC 1:1 Full Spectrum RSO Dablicator (1g) advanced to third place, showing a significant rise in sales compared to earlier months. Conversely, the THC/CBN 2:1 Nighttime Tincture (600mg THC, 300mg CBN, 1oz) experienced a drop in ranking, slipping to fourth in November 2025.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
